Correlation Between Onconova Therapeutics and Ardelyx
Can any of the company-specific risk be diversified away by investing in both Onconova Therapeutics and Ardelyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Onconova Therapeutics and Ardelyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Onconova Therapeutics and Ardelyx, you can compare the effects of market volatilities on Onconova Therapeutics and Ardelyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Onconova Therapeutics with a short position of Ardelyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Onconova Therapeutics and Ardelyx.
Diversification Opportunities for Onconova Therapeutics and Ardelyx
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Onconova and Ardelyx is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Onconova Therapeutics and Ardelyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ardelyx and Onconova Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Onconova Therapeutics are associated (or correlated) with Ardelyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ardelyx has no effect on the direction of Onconova Therapeutics i.e., Onconova Therapeutics and Ardelyx go up and down completely randomly.
Pair Corralation between Onconova Therapeutics and Ardelyx
If you would invest 102.00 in Onconova Therapeutics on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Onconova Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 0.53% |
| Values | Daily Returns |
Onconova Therapeutics vs. Ardelyx
Performance |
| Timeline |
| Onconova Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Ardelyx |
Onconova Therapeutics and Ardelyx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Onconova Therapeutics and Ardelyx
The main advantage of trading using opposite Onconova Therapeutics and Ardelyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Onconova Therapeutics position performs unexpectedly, Ardelyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ardelyx will offset losses from the drop in Ardelyx's long position.| Onconova Therapeutics vs. Jaguar Animal Health | Onconova Therapeutics vs. Ibio Inc | Onconova Therapeutics vs. GeoVax Labs | Onconova Therapeutics vs. Ocugen Inc |
| Ardelyx vs. BioLineRx | Ardelyx vs. Lexicon Pharmaceuticals | Ardelyx vs. Seres Therapeutics | Ardelyx vs. Immunitybio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |